Wealth Enhancement Advisory Services
FBIO icon

Wealth Enhancement Advisory Services’s Fortress Biotech FBIO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,017
Closed -$215K – 3686
2025
Q4 		$215K Buy
51,017
+20,266
+66% +$57.7K ﹤0.01% 3219
2025
Q3 		$93.8K Buy
30,751
+201
+0.7% +$508 ﹤0.01% 3346
2025
Q2 		$57.4K Hold
30,550
– – ﹤0.01% 3213
2025
Q1 		$47.7K Hold
30,550
– – ﹤0.01% 2854
2024
Q4 		$61.9K Hold
30,550
– – ﹤0.01% 2849
2024
Q3 		$44.1K Sell
30,550
-20,266
-40% -$38.6K ﹤0.01% 2627
2024
Q2 		$86.9K Sell
50,816
-120
-0.2% -$218 ﹤0.01% 2419
2024
Q1 		$102K Sell
50,936
-43,880
-46% -$87.3K ﹤0.01% 2290
2023
Q4 		$285K Sell
94,816
-7,984
-8% -$21.1K ﹤0.01% 1853
2023
Q3 		$448K Buy
+102,800
New +$705K ﹤0.01% 1496

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wealth Enhancement Advisory Services's FBIO Position: Q1 2026 in Review

Wealth Enhancement Advisory Services sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 51,017 shares — an estimated $215K sold.

Wealth Enhancement Advisory Services first reported a position in FBIO in Q3 2023 and held it in 10 quarters. The position peaked at $448K in Q3 2023. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Wealth Enhancement Advisory Services reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 51,017 Fortress Biotech shares in Q1 2026, an estimated $215K.
  • Wealth Enhancement Advisory Services first reported a position in Fortress Biotech in Q3 2023 and held it in 10 quarters.
  • Wealth Enhancement Advisory Services's Fortress Biotech position peaked at $448K in Q3 2023.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q1 2026, filed 8 Apr 2026.